Print Options
PrintThe Whole
Act
PrintThe Whole
Cross Heading
PrintThis
Section
only
Changes over time for: Section 2
Timeline of Changes
This timeline shows the different points in time where a change occurred. The dates will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. The first date in the timeline will usually be the earliest date when the provision came into force. In some cases the first date is 01/02/1991 (or for Northern Ireland legislation 01/01/2006). This date is our basedate. No versions before this date are available. For further information see the Editorial Practice Guide and Glossary under Help.
Version Superseded: 31/12/2020
Status:
Point in time view as at 01/04/2018. This version of this provision has been superseded.
Status
You are viewing this legislation item as it stood at a particular point in time. A later version of this or provision, including subsequent changes and effects, supersedes this version.
Note the term provision is used to describe a definable element in a piece of legislation that has legislative effect – such as a Part, Chapter or section.
Changes to legislation:
Human Fertilisation and Embryology Act 1990, Section 2 is up to date with all changes known to be in force on or before 16 November 2024. There are changes that may be brought into force at a future date. Changes that have been made appear in the content and are referenced with annotations.
Changes to Legislation
Changes and effects yet to be applied by the editorial team are only applicable when viewing the latest version or prospective version of legislation. They are therefore not accessible when viewing legislation as at a specific point in time. To view the ‘Changes to Legislation’ information for this provision return to the latest version view using the options provided in the ‘What Version’ box above.
2 Other terms.U.K.
(1)In this Act—
“the Authority” means the Human Fertilisation and Embryology Authority established under section 5 of this Act,
[“basic partner treatment services” means treatment services that are provided for a woman and a man together without using—
(a)
the gametes of any other person, or
(b)
embryos created outside the woman's body,]
[“competent authority”, in relation to an EEA state other than the United Kingdom or in relation to Gibraltar, means an authority designated in accordance with the law of that state or territory as responsible for implementing the requirements of the first, second[, third and fourth] Directives,]
“directions” means directions under section 23 of this Act,
[“distribution”, in relation to gametes or embryos intended for human application, means transportation or delivery [to any person in or outside the United Kingdom for human application], and related terms are to be interpreted accordingly,]
[“human application” means use in a human recipient,]
“licence” means a licence under Schedule 2 to this Act and, in relation to a licence, “the person responsible” has the meaning given by section 17 of this Act, and
[“non-medical fertility services” means any services that are provided, in the course of a business, for the purpose of assisting women to carry children, but are not medical, surgical or obstetric services,]
[“nuclear DNA”, in relation to an embryo, includes DNA in the pronucleus of the embryo,]
[“processing”, in relation to gametes or embryos intended for human application, means any operation involved in their preparation, manipulation or packaging, and related terms are to be interpreted accordingly,]
[“procurement”, in relation to gametes or embryos intended for human application, means any process by which they are made available, and related terms are to be interpreted accordingly,]
[“serious adverse event” means—
(a)
any untoward occurrence which may be associated with the procurement, testing, processing, storage or distribution of gametes or embryos intended for human application and which, in relation to a donor of gametes or a person who receives treatment services or non-medical fertility services—
(i)
might lead to the transmission of a communicable disease, to death, or life-threatening, disabling or incapacitating conditions, or
(ii)
might result in, or prolong, hospitalisation or illness, or
(b)
any type of gametes or embryo misidentification or mix-up,]
[“serious adverse reaction” means an unintended response, including a communicable disease, in a donor of gametes intended for human application or a person who receives treatment services or non-medical fertility services, which may be associated with the procurement or human application of gametes or embryos and which is fatal, life-threatening, disabling, incapacitating or which results in, or prolongs, hospitalisation or illness,]
[“store”, in relation to gametes[, embryos or human admixed embryos], means preserve, whether by cryopreservation or in any other way, and “storage” and “stored” are to be interpreted accordingly,]
[“traceability” means the ability—
(a)
to identify and locate gametes and embryos during any step from procurement to use for human application or disposal,
(b)
to identify the donor and recipient of particular gametes or embryos,
(c)
to identify any person who has carried out any activity in relation to particular gametes or embryos, and
(d)
to identify and locate all relevant data relating to products and materials coming into contact with particular gametes or embryos and which can affect their quality or safety,]
“treatment services” means medical, surgical or obstetric services provided to the public or a section of the public for the purpose of assisting women to carry children.
(2)References in this Act to keeping, in relation to embryos[, gametes or human admixed embryos ], include keeping while preserved [in storage].
[(2A)For the purposes of this Act, a person who, from any premises, controls the provision of services for transporting gametes or embryos [to any person in or outside the United Kingdom for human application] is to be taken to distribute gametes or embryos on those premises.
(2B)In this Act, any reference to a requirement of a provision of the first, second[, third or fourth] Directive is a reference to a requirement which that provision requires to be imposed.]
(3)For the purposes of this Act, a woman is not to be treated as carrying a child until the embryo has become implanted.
Textual Amendments
Commencement Information
Back to top